Correspondence 0001104659-23-001909 from American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
Date: Jan. 6, 2023 · CIK: 0001839998 · Accession: 0001104659-23-001909
AI Filing Summary & Sentiment
Show Raw Text
CORRESP 1 filename1.htm January 6, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Digital Transformation Opportunities Corp. Preliminary Proxy Statement Ladies and Gentlemen: On behalf of our client, Digital Transformation Opportunities Corp. (the “Company”), the Company is filing with the Securities and Exchange Commission a preliminary proxy statement relating to the Company’s proposed business combination with American Oncology Network, LLC (the “Proxy Statement”). Please contact Jonathan Ko of Paul Hastings LLP, counsel to the Company, by phone at (213) 683-6188 or by email at jonathanko@paulhastings.com regarding the Proxy Statement. Very truly yours, /s/ Jonathan Ko Jonathan Ko Paul Hastings LLP cc: Kevin Nazemi, Digital Transformation Opportunities Corp. David Gould, American Oncology Network, LLC David Hernand, Paul Hastings LLP Sahand Moarefy, Paul Hastings LLP Brian Lee, Dentons US LLP Ilan Katz, Dentons US LLP